THE Health Department has highlighted to prescribers that the deferasirox (Jadenau/Exjade) 'N'mg dispersible tablet and 'N'mg film coated tablet are equivalent for the purposes of substitution, but are not a-flagged to permit pharmacist substitution in the dispensary.
The Pharmaceutical Benefits Scheme website details the issue, noting a change will be made to clinical criteria in the PBS Schedule on 01 Feb 2019 - pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Dec 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Dec 18
